- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06144541
Correlation Between Objective Skin Pigment Measurement and Fitzpatrick Skin Type
Study Overview
Status
Conditions
Detailed Description
The Fitzpatrick scale is a numerical classification for human skin color developed in 1975 as a way to estimate the response of different types of skin to UV light. It is used by dermatologists to classify skin tone and assess the risk of skin cancer.
The Fitzpatrick scale encompasses six gradings, from I to VI. However, this does not include all skin tones, as there are significantly more not encompassed within the scale. The aim of this study is to incorporate objective measurements when identifying a patient's Fitzpatrick skin type.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Raja Sivamani, MD
- Phone Number: 916-524-1216
- Email: raja.sivamani@integrativeskinresearch.com
Study Locations
-
-
California
-
Sacramento, California, United States, 95815
- Recruiting
- Integrative Skin Science & Research
-
Contact:
- Raja Sivamani, MD MS AP
-
Principal Investigator:
- Raja Sivamani, MD MS AP
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male and females that are 18 years of age and older
- Subjects with all Fitzpatrick skin types I-VI One-third of subjects will be Fitzpatrick I or II skin types, one-third of subjects will be III or IV, and one-third will have V and VI.
Exclusion Criteria:
- Individuals who are pregnant or breastfeeding.
- Prisoners
- Adults unable to consent
- Individuals with open wounds on the nondominant upper inner arm
- Individuals with fibrotic skin disease or other skin conditions or hair growth on the nondominant upper inner arm that could affect skin measurements in the opinion of the investigator
- Individuals with tattoos that cover the site on the nondominant upper inner arm
- Individuals with post-inflammatory hypopigmentation or hyperpigmentation
- Individuals with vitiligo
- Individuals who have used self-tanning products or tanning beds in the last two weeks.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
General public
This survey and ITA measurements will be performed among the general public
|
Survey administration for Fitzpatrick skin type
Measurement of ITA based on SkinColorCatch instrument
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin colorimeter derived Individual Typology Angle value correlated against self-reported Fitzpatrick skin type
Time Frame: One time - collected for up to 1 year for the entire study
|
Correlation of ITA by the use of SkinColorCatch (Delfin) compared to the Fitzpatrick skin scale as determined by the patients' responses to validated questionnaire. The higher the ITA, the lighter the skin. ITA skin color types are classified into six groups, from Very Light to Dark skin. |
One time - collected for up to 1 year for the entire study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess Fitzpatrick Skin type based on validated questionnaire
Time Frame: One time - collected for up to 1 year for the entire study
|
Questionnaire about sun sensitivity and tanning will be administered to calculate the Fitzpatrick skin types
|
One time - collected for up to 1 year for the entire study
|
|
Sun protection habit use
Time Frame: One time - collected for up to 1 year for the entire study
|
Quantification of sun protection habits based on survey question asking their typical use of sun protection
|
One time - collected for up to 1 year for the entire study
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- i23-09_Fitz_Skin
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Pigment
-
Wageningen UniversityCompleted
-
University of Texas Southwestern Medical CenterCompleted
-
Unilever R&DMS Clinical Research Pvt. LtdCompleted
-
NovoBliss Research Pvt LtdVasu Healthcare Private LimitedCompletedHealthy | Wrinkle | Skin Pigment | Dry SkinIndia
-
University of California, DavisCompletedErythema | Microbiome | Skin Pigment | Side Effect | Wrinkle Appearance | LipidomeUnited States
-
The Lowy Medical Research Institute LimitedUnknownMacular Pigment | Macular TeleangiectasiaGermany
-
Vitreous -Retina- Macula Consultants of New YorkRegeneron PharmaceuticalsWithdrawnFibrovascular Pigment Epithelial DetachmentUnited States
-
University of California, San FranciscoFood and Drug Administration (FDA)CompletedHypoxemia | Skin Pigment | Pulse OximetryUnited States
-
NovoBliss Research Pvt LtdGreen Mountain Biotech LimitedCompletedAging | Wrinkle | Pigment SkinIndia
Clinical Trials on Survey administration for Fitzpatrick skin type
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminated
-
Fred Hutchinson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedMalignant NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMobile Health Intervention in Increasing HPV Vaccine Coverage Among Young Adult Gay and Bisexual MenHealthy SubjectUnited States
-
Chongqing Claruvis Pharmaceutical Co., Ltd.Recruiting
-
JHM BioPharma (Tonghua) Co. , Ltd.Not yet recruitingUpper Limb Spasticity (ULS)China